Wake Forest University School of Medicine
Dr. Lieu joined the University of Colorado School of Medicine faculty as an Assistant Professor in July 2011. He trained in internal medicine at the University of Colorado, where he also served as a Chief Medical Resident. He completed his fellowship training in medical oncology at the University of Texas MD Anderson Cancer Center and served as the Chief Medical Oncology Fellow in 2010.
Dr. Lieu is a member of the Developmental Therapeutics (phase
I clinical trials) and Gastrointestinal (GI) Medical Oncology Program. These comprehensive programs include
multidisciplinary cancer clinics, tumor boards, and research endeavors. Dr. Lieu is interested in resistance
mechanisms to targeted therapy in GI cancers, and he was awarded the 2010 ASCO
Cancer Foundation Young Investigators Award to study alternate angiogenic
cytokines in colorectal cancer.
Lieu C, Chow L, Pierson A, Eckhardt SG, O’Bryant CL, Morrow M, Tran ZV, Wright JJ, Gore L. A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy. Invest New Drugs 2009;27(1):53-62. PMID: 18618082
- Lieu C, Kopetz S. Src family of protein kinases: a new and promising target for colorectal cancer. Clin Colorectal Cancer 2010;9(2):89-94. PMID: 20378502
- Lieu CH, Lambert LA, Wolff RA, Eng C, Zhang N, Wen S, Rafeeq S, Taggart M, Fournier K, Royal R, Mansfield P, Overman MJ. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol 2011:10.1094/annonc/mdr279. PMID: 21653683
- Lieu CH, Heymach JV, Overman MJ, Tran H, Kopetz S. Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis. Clin Cancer Res 2011. doi: 10:1158/1078-0432. CCR-11-0659.
K12 Paul Calabresi Career Development Award for Clinical Oncology
Cancer Foundation Young Investigators Award